Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis
OBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP).
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1995-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/1995/948507 |
id |
doaj-713d5652f0d8464dbdfab43f4186ac7e |
---|---|
record_format |
Article |
spelling |
doaj-713d5652f0d8464dbdfab43f4186ac7e2021-07-02T04:45:21ZengHindawi LimitedCanadian Respiratory Journal1198-22411995-01-0121495410.1155/1995/948507Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine ProphylaxisRA McIvor0AR Rachlis1P Berger2LR Lee Pack3Charles K Chan4Department of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, CanadaDepartment of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, CanadaDepartment of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, CanadaDepartment of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, CanadaDepartment of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, CanadaOBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP).http://dx.doi.org/10.1155/1995/948507 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
RA McIvor AR Rachlis P Berger LR Lee Pack Charles K Chan |
spellingShingle |
RA McIvor AR Rachlis P Berger LR Lee Pack Charles K Chan Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis Canadian Respiratory Journal |
author_facet |
RA McIvor AR Rachlis P Berger LR Lee Pack Charles K Chan |
author_sort |
RA McIvor |
title |
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis |
title_short |
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis |
title_full |
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis |
title_fullStr |
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis |
title_full_unstemmed |
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis |
title_sort |
risk factors for breakthrough pneumocystis carinii pneumonia on aerosol pentamidine prophylaxis |
publisher |
Hindawi Limited |
series |
Canadian Respiratory Journal |
issn |
1198-2241 |
publishDate |
1995-01-01 |
description |
OBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP). |
url |
http://dx.doi.org/10.1155/1995/948507 |
work_keys_str_mv |
AT ramcivor riskfactorsforbreakthroughpneumocystiscariniipneumoniaonaerosolpentamidineprophylaxis AT arrachlis riskfactorsforbreakthroughpneumocystiscariniipneumoniaonaerosolpentamidineprophylaxis AT pberger riskfactorsforbreakthroughpneumocystiscariniipneumoniaonaerosolpentamidineprophylaxis AT lrleepack riskfactorsforbreakthroughpneumocystiscariniipneumoniaonaerosolpentamidineprophylaxis AT charleskchan riskfactorsforbreakthroughpneumocystiscariniipneumoniaonaerosolpentamidineprophylaxis |
_version_ |
1721339576974311424 |